As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: October 3, 2013
by Faith Trussell, RN, BSN for El Dorado Springs Sun:
Most of us know someone who has dementia – a progressive decline in mental functioning that affects memory, mood, concentration, judgment, reasoning, and thinking. Dementia can be caused by a number of things, most often Alzheimer’s Disease or vascular disease.
However, an older adult may have difficulty thinking clearly, concentrating, and making decisions, and may appear confused, masking dementia, when in reality these symptoms may be due to depression. When depression creates cognitive symptoms that look like Alzheimer’s or another type of dementia, it’s often referred to as pseudodementia.
Diagnosing pseudodementia is complicated, but a thorough assessment can reveal important clues. For instance, people with depression might complain of memory impairment, but upon careful testing, they often do well on mental status exams and other tests that evaluate cognitive and language functioning. On the other hand, people with true dementia often deny any memory problems but don’t score as well on mental status exams.
It is important that anyone experiencing a marked deterioration in mental abilities be evaluated by a qualified professional. One of several screening instruments is the Geriatric Depression Scale, which detects depression in older adults. Depression and pseudodementia can be reversed, and often respond well to a combination of medication and psychotherapy.
Note: This column is provided by Senior Life Solutions, a program dedicated to addressing the emotional health of adults over the age of 65.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.